Evidence map›Paper›PMID 36837485›Full record

Observational studyMedicina (Kaunas, Lithuania)2023

Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021.

Cvetka Bačar Bole, Katja Nagode, Mitja Pišlar, Aleš Mrhar, Iztok Grabnar, Tomaž Vovk

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cvetka Bačar BolePsychiatric Hospital Idrija, 5280 Idrija, Slovenia.
Katja NagodeFaculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Mitja PišlarFaculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Aleš MrharFaculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Iztok GrabnarFaculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3452-1499
Tomaž VovkFaculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-3322-4807
University of Ljubljana · SI

Funding

Slovenian Research Agency P1-0189
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsSchizophreniaCross-Sectional StudiesDrug InteractionsHumansPrevalenceRisk FactorsAntipsychotic Agentsantipsychoticsdrug interaction programpotential drug—drug interactionsrisk factorsschizophreniasymptoms and signs

Identifiers

PMID36837485
PMCPMC9962414
OpenAlexW4318777087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.